title: Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance.
authors.forename: Claudio
authors.initials: C
authors.lastname: Sandoval
authors.forename: Joseph
authors.initials: J
authors.lastname: Giamelli
authors.forename: Somasundaram
authors.initials: S
authors.lastname: Jayabose
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome; D016312:Treatment Refusal
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate